Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the combination of idetrexed and olaparib in patients with high-grade serous ovarian cancer; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Idetrexed
  • Olaparib (Olaparib)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: High Grade Serous Ovarian Cancer | Phase 1 | Status: RECRUITING